The trial results demonstrated a favorable safety and tolerability profile consistent with GLP-1-based treatments and previously reported HRS9531 Phase 2 clinical data. Most treatment-emergent adverse ...

More than 75 percent of Gabriel House residents are enrolled in Medicaid, state officials have said, and it charges ...

The Metro West Home Team, founded and run by veteran broker Stewart Woodward, has once again proven why he’s a fixture among ...

The nationwide protests are in response to the Trump administration’s efforts to undermine civil rights and democratic ...

Valued at a market cap of $11.6 billion, Revvity, Inc. (RVTY) provides health sciences solutions, technologies, and services. The Waltham, Massachusetts-based company serves pharmaceutical and ...

The battle between Waltham-based Global Partners and Irish retailer Applegreen has been good for local lobbying firms.

Teamsters have alleged that their decision to strike on July 1 was caused by Republic Services’ refusal to agree to pay them ...

Applegreen said it's investing $750 million to rebuild nine highway service plazas and renovate the other nine.

Apogee Therapeutics, Inc.'s APG777 shows promising week-16 efficacy and dosing potential, targeting the AT market. Click for ...

J.P. Morgan, Leerink Partners and Guggenheim Securities are acting as joint book-running managers for the offering. LifeSci Capital is also acting as lead manager for the offering.

Businesses that distinguish themselves with exceptional investment in their employees were just named to Inc.’s Best ...